Related Experiment Video

Updated: May 10, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.1K

Systemic Therapy for Metastatic Colon Cancer: New Frontiers

Yoanna S Pumpalova1

  • 1Division of Hematology and Oncology, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York.

Clinics in Colon and Rectal Surgery
|April 28, 2025
PubMed

Insights

Advances in metastatic colon cancer treatment show improved survival through biomarker-driven therapies and combination chemotherapy. New targeted treatments and strategies are emerging for unresectable cases.

Area of Science:

  • Oncology
  • Medical Oncology
  • Gastrointestinal Oncology

Background:

  • Significant progress has been made in improving overall survival for patients with metastatic, unresectable colon cancer over the past decade.
  • Combination chemotherapy remains a primary treatment modality, but the field is shifting towards biomarker-driven approaches.
  • The emergence of targeted therapies offers new hope and treatment avenues.

Purpose of the Study:

  • To review current biomarkers relevant to colon cancer treatment.
  • To summarize the standard of care for first-, second-, and third-line treatment of metastatic, unresectable colon cancer.
  • To introduce novel therapeutic strategies and agents under investigation.

Main Methods:

  • Literature review focusing on biomarker-driven therapies in colon cancer.
  • Analysis of standard of care treatment guidelines for metastatic, unresectable colon cancer.
  • Exploration of ongoing clinical trials and emerging therapeutic agents.

Main Results:

  • The review outlines key biomarkers that guide treatment decisions in colon cancer.
  • It details current first-, second-, and third-line systemic treatment options.
  • Promising new targeted therapies and innovative treatment strategies are highlighted.

Conclusions:

  • Treatment for metastatic, unresectable colon cancer is increasingly personalized and biomarker-directed.
  • Combination chemotherapy remains foundational, complemented by emerging targeted agents.
  • Ongoing research into novel therapies promises further improvements in patient outcomes.
Keywords:
investigational agentsmetastatic colon cancersystemic therapy

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.6K
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K